Skip to content

Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis

Effectiveness of Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Comparison to Standard Care in Children With Bronchiolitis: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04989114
Enrollment
96
Registered
2021-08-04
Start date
2020-09-06
Completion date
2021-09-05
Last updated
2021-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis Acute Viral, Bronchiolitis, Bronchiolitis Acute, Bronchiolitis, Viral, Nasal Continuous Positive Airway Pressure

Brief summary

This study is designed to assess the effectiveness of nasal continuous positive airway pressure in reducing respiratory distress in children with bronchiolitis

Detailed description

In this study, after taking consent from caretakers, patients of brochiolitis will be randomly assigned to either a standard care group or a nasal continuous positive airway pressure group. Both groups will be followed for respiratory distress. Respiratory distress will be compared by using Seattle sore of respiratory distress.

Interventions

positive end expiratory pressure will be applied by nasal continuous positive airway pressure

Sponsors

King Edward Medical University
CollaboratorOTHER
ameer asadullah gull
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Months to 2 Years
Healthy volunteers
No

Inclusion criteria

* Children presenting with history of cough, and tachypnea and wheezing on clinical examination

Exclusion criteria

* Patients needing mechanical ventilation at the time of admission * Patients whose caretakers refuse written informed consent * Patients having consolidation on chest X-Ray

Design outcomes

Primary

MeasureTime frameDescription
reduction in seattle scoreafter 12 hoursseattle score will be noted and compared for both groups

Countries

Pakistan

Contacts

Primary ContactAmeer Asadullah Gull, MBBS
hellowgull@yahoo.com00923084860184
Backup ContactMuhammad Haroon Hamid, MBBSFCPSFRCS
haroonr5@yahoo.com00923008880916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026